Products for Research Use Only

PTC299

CAT: 0013-GTR19175915-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19175915-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PTC299 is an orally bioavailable small molecule that selectively inhibits VEGFA protein synthesis post-transcriptionally and potently targets dihydroorotate dehydrogenase (DHODH) . It has been investigated in preclinical in vitro and in vivo studies for its potential application in angiogenesis-dependent research areas, including oncology.
CAS Number
1256565-36-2
Product Name Alternative
Dihydroorotate Dehydrogenase, DHODH, DNA/RNA Synthesis, cancer, (4-chlorophenyl) (1S) -6-chloro-1- (4-methoxyphenyl) -1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate, oral, off-target, kinase, inhibit, myelosuppression, malignancies, hematologic, Inhibitor, Emvododstat, PTC299, PTC-299, PTC 299, Vascular endothelial growth factor receptor, VEGFR
Field of Research
Cardiovascular Research, Cell Biology, Metabolism Research, Molecular Biology, Signal Transduction
Purity
99.19% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:1 mg/mL (2.14 mM) ; DMSO:50 mg/mL (106.99 mM)
Smiles
COc1ccc (cc1) [C@@H]1N (CCc2c1[nH]c1ccc (Cl) cc21) C (=O) Oc1ccc (Cl) cc1
Molecular Formula
C25H20Cl2N2O3
Molecular Weight
467.34
Storage Conditions
-20°C
Notes
For research use only.